tiprankstipranks
Verve Therapeutics (VERV)
NASDAQ:VERV
US Market

Verve Therapeutics (VERV) Balance Sheet

368 Followers

Verve Therapeutics Balance Sheet

Verve Therapeutics's total assets for Q3 2023 were $612.41M, an increase of 3.95% from the previous quarter. VERV total liabilities were $152.04M for the fiscal quarter, a 22.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 679.22M$ 376.90M$ 78.41M$ 21.65M
Total Liabilities
$ 128.29M$ 26.77M$ 142.32M$ 41.20M
Total Equity Gross Minority
$ 550.93M$ 357.35M$ -63.91M$ -19.55M
Total Capitalization
$ 620.95M$ 357.35M$ -63.91M$ -19.55M
Preferred Stock Equity
----
Capital Lease Obligations
--$ 0.00-
Currency in USD

Verve Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis